Journal profile · ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL

American Journal of Translational Research

ISSN 1943-8141 · e-Century Publishing Corporation · UNITED STATES

American Journal of Translational Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.78; fully open access; APC about USD 1,880; median 67 days to acceptance (180 articles, last 24 months); 870 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.

Impact factor1.78Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time67 daysMedian, submission to acceptance · 180 articles, last 24 months · PubMed
APCUSD 1,880Fully open access
Acceptance—No reports yet
Articles per year8702025 · OpenAlex count

Scope

Aims, scope and focus

American Journal of Translational Research is published by e-Century Publishing Corporation and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Inflammatory Biomarkers in Disease Prognosis, Ferroptosis and cancer prognosis and Enhanced Recovery After Surgery, together about 18.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

American Journal of Translational Research (AJTR, ISSN 1943-8141) is an open access online journal dedicated to original clinical and experimental research papers, but will also publish editorials, review articles, medical hypothesis, letters to the editors and meeting reports. The goal of AJTR is to provide a free forum for rapid dissemination of the novel discoveries in translational research.

From the journal's Aims & Scope

Research area (LetPub): ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL

Editor-in-chief Liang ChengPublisher website

Editorial board by country: 24 in mainland China (about 13%); most named United States 99, Mainland China 24, United Kingdom 10, Italy 9, Taiwan, China 6 (185 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Inflammatory Biomarkers in Disease PrognosisMedicine6.7%
  2. Ferroptosis and cancer prognosisMedicine6.6%
  3. Enhanced Recovery After SurgeryMedicine5.4%
  4. Cancer Immunotherapy and BiomarkersMedicine4.9%
  5. Pregnancy and preeclampsia studiesMedicine4.9%
  6. Acupuncture Treatment Research StudiesMedicine4.8%
  7. Anesthesia and Pain ManagementMedicine4.5%
  8. Chronic Kidney Disease and DiabetesMedicine4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, Research & ExperimentalZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4
MinorMedicine, Research & ExperimentalZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, Research & ExperimentalZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

Early warning / risk: CAS Early Warning Journal List: listed in the 2023 edition (medium risk) and the 2020 edition (medium risk); not listed in the other 4 editions.LetPub

Indexing the journal's website claims

Web of SciencePMCPubMedPublisher website

Other: Google Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.78LetPub ·
CiteScore 2026-06
5.3LetPub ·
SJR 2026-06
1.03LetPub ·
SNIP 2026-06
0.9LetPub ·
h-index
45LetPub ·
h-index
17OpenAlex ·
i10-index
49OpenAlex ·
2-year mean citedness
1.59OpenAlex ·
Self-citation rate
5.6%LetPub ·
Share of gold OA articles
1.4%LetPub ·

Volume

Articles per year
864LetPub ·

Articles by year OpenAlex count · 2,226 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026628594111
20258708121,118
20247257252,314
2021100

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

67 daysMedian, submission to acceptance · P25–P75 48 days – 93 days

Acceptance to online
median 43 days (180 articles)
Submission to online
median 110 days
Sample
180 articles with submission and acceptance dates (1,719 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Peer review
Single-anonymous peer reviewPublisher website · model-extracted

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
Publisher websiteUSD 1,880——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare3 items from the author guidelines
Reference style
AMA
Suggested reviewers
Optional, 5
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted6
  1. editorialswill also publish editorials, review articles, medical hypothesis, letters to the editors and meeting reportsLength not stated
  2. letters to the editorswill also publish editorials, review articles, medical hypothesis, letters to the editors and meeting reportsLength not stated
  3. medical hypothesiswill also publish editorials, review articles, medical hypothesis, letters to the editors and meeting reportsLength not stated
  4. meeting reportswill also publish editorials, review articles, medical hypothesis, letters to the editors and meeting reportsLength not stated
  5. original clinical and experimental research papersdedicated to original clinical and experimental research papersLength not stated
  6. review articleswill also publish editorials, review articles, medical hypothesis, letters to the editors and meeting reportsLength not stated
Publisher website
Policy excerpts from the journal's websitePublication ethics, Peer review
Publication ethics

Editors follow COPE procedures for complaints. Model summary

To adopt and follow reasonable procedures in the event of any complaints, ethical or otherwise, in accordance with the policies and procedures of COPE (www.publicationethics.org).

Source ↗Publisher website ·
Peer review

Peer review policy: all manuscripts are subject to peer review; authors may provide up to five potential peer reviewers with contact information; recommended reviewers who have been coauthors with the corresponding author within five years prior to submission will not be used; reviewers recommended Model summary

All manuscripts are subject to peer review and are expected to meet the rigorous standards of academic excellence.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
e-Century Publishing Corporation
Country or region
UNITED STATES
Language
English
ISSN
1943-8141
Official links

FAQ

Frequently asked questions about American Journal of Translational Research

What CAS zone is American Journal of Translational Research in?

In the 2025 upgraded edition of the CAS Journal Ranking, American Journal of Translational Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of American Journal of Translational Research?

The latest impact factor listed by LetPub is 1.78; CiteScore 5.3, h-index 17.

How long does peer review take at American Journal of Translational Research?

Based on the dates recorded on 180 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 48–93 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of American Journal of Translational Research?

According to the journal's author guidelines: Reference style: AMA; Suggested reviewers: Optional, 5; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of American Journal of Translational Research based?

Of the 185 board members whose country the journal's board page names, 24 (about 13%) are in mainland China; the countries named most often are United States (99), Mainland China (24) and United Kingdom (10). Counted from the institutions listed on the board page; for reference only.

Which databases index American Journal of Translational Research?

According to LetPub and DOAJ records, American Journal of Translational Research is indexed in SCIE and Scopus. The journal's website also lists Web of Science, PMC and PubMed; that list has not been checked against each database.

Is American Journal of Translational Research open access, and what is the APC?

American Journal of Translational Research is a fully open-access journal. APC about USD 1,880.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .